Latest Financial Updates

Read latest financial news update from our blog

New Investor Ideas (TSXV: SRQ) (TSXV: PLSR) (TSXV: RGC) (Nasdaq: SPGC) (Nasdaq: IVP) (Nasdaq: SRM)
New Investor Ideas (TSXV: SRQ) (TSXV: PLSR) (TSXV: RGC) (Nasdaq: SPGC) (Nasdaq: IVP) (Nasdaq: SRM)

September 22, 2023 (Investorideas.com Newswire) Investorideas.com, a global news source an...

Admin | Finance | 3 months ago

US business activity nears stand-still in September, survey says
US business activity nears stand-still in September, survey says

(Sept 22): US business activity showed little change in September, with the vast services...

Admin | Finance | 3 months ago

Eli Lilly, Boehringer Ingelheim’s Jardiance gets FDA approval for chronic kidney disease
Eli Lilly, Boehringer Ingelheim’s Jardiance gets FDA approval for chronic kidney disease

Eli Lilly & Co. LLY, -3.42% and Boehringer Ingelheim said Friday that the U.S. Food and Dr...

Admin | Finance | 3 months ago

Palantir’s CEO has this message for skeptics and believers alike
Palantir’s CEO has this message for skeptics and believers alike

Palantir Technologies Inc. is a polarizing stock, racking up a 118% surge so far this year...

Admin | Finance | 3 months ago

Microsoft's first AI chat ad format—what brands need to know about the ads
Microsoft's first AI chat ad format—what brands need to know about the ads

Microsoft came hot out of the gate this year with its push to invest into OpenAI and to in...

Admin | Finance | 3 months ago

Tech money is finally flowing again, and it may be just the beginning
Tech money is finally flowing again, and it may be just the beginning

When the financial fantasyland of 2021 came to an end, the rivers of cash that had been fl...

Admin | Finance | 3 months ago

Meta Stock Has Room to Soar. How Ads and AI Can Drive Growth.
Meta Stock Has Room to Soar. How Ads and AI Can Drive Growth.

Meta Platforms stock could gain significantly in the next three months, driven by advertis...

Admin | Finance | 3 months ago

Eli Lilly set to dominate obesity drug market into the next decade, analysts say
Eli Lilly set to dominate obesity drug market into the next decade, analysts say

Eli Lilly & Co. LLY, -3.42% is best positioned to dominate the fast-growing U.S. market fo...

Admin | Finance | 3 months ago

Join Our Newsletter

join our newsletter to receive update from us